We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$6.97B
AUM Growth
+$4.79B
(+220%)
Cap. Flow
+$6.91B
Cap. Flow
% of AUM
99.25%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,371
Increased
1,984
Reduced
143
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 100 ETF
OEF
|
+$2.43B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.24B |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$202M |
| 4 |
American Century Diversified Corporate Bond ETF
KORP
|
+$152M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$91.2M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$62.6M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$58.1M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$46.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.48% |
| 2 | Financials | 8.05% |
| 3 | Industrials | 7.03% |
| 4 | Consumer Discretionary | 6.62% |
| 5 | Healthcare | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Protolabs
PRLB
$2.14B
| $22.9K | ﹤0.01% |
458
+443
| +2,953% | +$20.3K |
|
2202
AMES National
ATLO
$277M
| $22.7K | ﹤0.01% |
+1,125
| New | +$21.7K |
|
2203
BioCryst Pharmaceuticals
BCRX
$2.4B
| $22.7K | ﹤0.01% |
2,993
+2,290
| +326% | +$19.1K |
|
2204
iRhythm Holdings
IRTC
$4.14B
| $22.7K | ﹤0.01% |
+132
| New | +$21K |
|
2205
PDF Solutions
PDFS
$2.1B
| $22.7K | ﹤0.01% |
879
+757
| +620% | +$16.5K |
|
2206
Editas Medicine
EDIT
$454M
| $22.7K | ﹤0.01% |
6,529
+6,379
| +4,253% | +$17.8K |
|
2207
Kenvue
KVUE
$36.7B
| $22.7K | ﹤0.01% |
1,396
-7,335
| -84% | -$150K |
|
2208
Neumora Therapeutics
NMRA
$306M
| $22.6K | ﹤0.01% |
+12,445
| New | +$20.1K |
|
2209
FTAI Aviation
FTAI
$23.2B
| $22.5K | ﹤0.01% |
135
+107
| +382% | +$15.2K |
|
2210
Hyster-Yale Materials Handling
HY
$701M
| $22.5K | ﹤0.01% |
611
+483
| +377% | +$18.8K |
|
2211
Infosys
INFY
$50.2B
| $22.4K | ﹤0.01% |
1,379
+428
| +45% | +$7.37K |
|
|
VTYX
2212
DELISTED
Ventyx Biosciences
VTYX
| $22.4K | ﹤0.01% |
+7,203
| New | +$19.1K |
|
2213
Alpha and Omega Semiconductor
AOSL
$1.03B
| $22.4K | ﹤0.01% |
801
+639
| +394% | +$17.7K |
|
2214
United States Oil Fund
USO
$1.84B
| $22.3K | ﹤0.01% |
302
| – | – |
|
2215
American Airlines Group
AAL
$10.8B
| $22.2K | ﹤0.01% |
1,979
-2,795
| -59% | -$34.4K |
|
2216
Mayville Engineering Co
MEC
$666M
| $22.2K | ﹤0.01% |
+1,616
| New | +$24.3K |
|
2217
NETGEAR
NTGR
$653M
| $22.2K | ﹤0.01% |
686
+659
| +2,441% | +$18K |
|
2218
IDT Corp
IDT
$1.65B
| $22.2K | ﹤0.01% |
+424
| New | +$26.4K |
|
|
EMBJ
2219
Embraer S.A. ADS
EMBJ
$12.8B
| $22.1K | ﹤0.01% |
366
-463
| -56% | -$26.1K |
|
|
RPTX
2220
DELISTED
Repare Therapeutics
RPTX
| $22K | ﹤0.01% |
12,500
+7,500
| +150% | +$12K |
|
2221
Lindblad Expeditions
LIND
$2.24B
| $22K | ﹤0.01% |
1,717
+1,626
| +1,787% | +$21.4K |
|
2222
Colony Bankcorp
CBAN
$469M
| $21.9K | ﹤0.01% |
+1,290
| New | +$22K |
|
2223
Talos Energy
TALO
$2.37B
| $21.9K | ﹤0.01% |
2,287
+2,202
| +2,591% | +$19.8K |
|
2224
Equity Lifestyle Properties
ELS
$12.6B
| $21.9K | ﹤0.01% |
361
+320
| +780% | +$19.4K |
|
|
PLYM
2225
DELISTED
Plymouth Industrial REIT
PLYM
| $21.9K | ﹤0.01% |
981
+740
| +307% | +$13.6K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,371 new positions and adding to 1,984 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.
- Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
- Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
- Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
- Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
- Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
- Arax Advisory Partners opened 1,371 new positions and closed 794 in Q3 2025.
- Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.
Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.